PMID: 9534037Apr 16, 1998Paper

Treatment of hyperthyroidism with radioactive iodine

Endocrinology and Metabolism Clinics of North America
M M KaplanH J Dworkin

Abstract

Treatment of hyperthyroidism with RAI has been performed for more than a half century with efficacy and safety. For its optimal use, the physician must employ appropriate patient selection criteria and clinical judgment concerning pretreatment patient preparation. The dose of the 131I needed remains an area of uncertainty and debate; thus far, it has not been possible to resolve the trade-off between efficient definitive cure of hyperthyroidism and the high incidence of post-therapy hypothyroidism. Early side effects are uncommon and readily manageable. Other than the need for long-term monitoring and, in most cases, lifelong L-T4 treatment, late adverse consequences of this treatment remain only conjectural. The available follow-up studies support the current majority opinion of North American thyroid specialists that RAI treatment is an excellent choice for most hyperthyroid patients.

References

Dec 20, 1975·Lancet·P H WiseP E Harding
Dec 1, 1977·Disease-a-month : DM·J R Hurley
Jul 1, 1978·Annals of Internal Medicine·C A Gorman, J S Robertson
Apr 1, 1977·Clinical Endocrinology·M Schimmel, R D Utiger
Jan 1, 1992·Thyroid : Official Journal of the American Thyroid Association·C MarcocciA Pinchera
Jun 1, 1990·The Journal of Clinical Endocrinology and Metabolism·B SolomonL Wartofsky
Nov 16, 1989·The New England Journal of Medicine·M F PrummelW M Wiersinga
Dec 1, 1988·Clinical Nuclear Medicine·M LakshmananJ Norton
Sep 14, 1967·The New England Journal of Medicine·G A HagenE M Chapman
Sep 16, 1968·JAMA : the Journal of the American Medical Association·E L SaengerE A Tompkins
May 15, 1969·The New England Journal of Medicine·J I Hamburger
Jan 1, 1966·Acta Endocrinologica·F K Bauer, B Catz
Feb 1, 1983·The Journal of Clinical Endocrinology and Metabolism·L HegedüsJ M Hansen
Mar 1, 1983·Clinical Nuclear Medicine·H R MaxonI W Chen
Feb 1, 1980·The Journal of Clinical Endocrinology and Metabolism·J S SawersJ Seth
Oct 15, 1994·Annals of Internal Medicine·H B BurchK D Burman
Jun 16, 1994·The New England Journal of Medicine·J A Franklyn
Nov 15, 1994·Annals of Internal Medicine·D A HuysmansP W Kloppenborg
Nov 11, 1993·The New England Journal of Medicine·R S Bahn, A E Heufelder
Mar 1, 1993·Nuclear Medicine Communications·M J O'DohertyA J Coakley
Aug 1, 1996·Postgraduate Medical Journal·E B JudeP M Dodson
Apr 1, 1997·Thyroid : Official Journal of the American Thyroid Association·C T Sawin, D V Becker
Apr 1, 1997·Thyroid : Official Journal of the American Thyroid Association·P Hall, L E Holm
Apr 1, 1997·Thyroid : Official Journal of the American Thyroid Association·L Wartofsky
Apr 1, 1997·Thyroid : Official Journal of the American Thyroid Association·D HuysmansP Kloppenborg
Apr 1, 1997·Thyroid : Official Journal of the American Thyroid Association·L Tallstedt, G Lundell
Apr 1, 1997·Thyroid : Official Journal of the American Thyroid Association·L J DeGroot
Jun 1, 1955·The Journal of Clinical Endocrinology and Metabolism·R E HODGESW C KEETTEL
May 1, 1995·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·G H Tan, H Gharib

❮ Previous
Next ❯

Citations

Dec 20, 2000·Fertility and Sterility·G E Krassas
Jul 11, 2001·Endocrinology and Metabolism Clinics of North America·D A Meier, M M Kaplan
Jul 5, 2002·Thyroid : Official Journal of the American Thyroid Association·C S BalR M Pandey
Feb 27, 2014·Nuclear Medicine Communications·Boris ShapiroRoman Schipper
Dec 26, 2009·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Antoine DigonnetGuy Andry
Mar 11, 2008·World Journal of Surgery·Peter StålbergPer Hellman
Aug 15, 2001·The Journal of Clinical Endocrinology and Metabolism·A AllahabadiaJ A Franklyn
Jan 16, 2007·Arquivos brasileiros de endocrinologia e metabologia·Marcus V L de SouzaRonir Raggio Luiz
Nov 24, 1999·The Journal of Clinical Endocrinology and Metabolism·V A AndradeA L Maia
May 13, 2003·Journal of Endocrinological Investigation·F BogazziL Bartalena
Apr 12, 2003·American Journal of Clinical Dermatology·Serge A Jabbour
Jul 5, 2003·Journal of Endocrinological Investigation·G E Krassas, P Perros
Apr 4, 2018·Nuclear Medicine Communications·Steve L HyerGlenn D Flux
Apr 1, 2004·Head & Neck·Ranjiv SivanandanKhee Chee Soo
Jan 12, 2007·The Annals of Otology, Rhinology, and Laryngology·Joshua L ScharfAhmed M S Soliman
Jul 30, 2014·Advanced Drug Delivery Reviews·Lihong BuZhen Cheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.